呼吸器吸入器市場：製品タイプ、年齢層、モード、適応疾患、エンドユーザー別-2025-2030年の世界予測

呼吸器吸入器市場は、2023年に29億6,000万米ドルと評価され、2024年には32億4,000万米ドルに達すると予測され、CAGR 9.74％で成長し、2030年には56億8,000万米ドルになると予測されています。

呼吸器吸入器市場は、主に喘息やCOPDのような慢性呼吸器疾患を持つ人々のために、肺に直接薬剤を送達するために使用されるさまざまなデバイスを包含します。これらの吸入器の必要性は、大気汚染、喫煙、老人人口の増加によって呼吸器疾患の有病率が増加していることから生じています。その用途は、迅速な緩和や長期的な薬物制御を提供し、それによって患者のコンプライアンスと生活の質を向上させる上で重要です。最終用途は、在宅介護の現場、病院、診療所など多岐にわたっており、携帯可能で使いやすい機器の必要性が強調されています。市場成長に影響を与える主な要因には、投与量の追跡や患者リマインダーを提供し、服薬アドヒアランスを高めるスマート吸入器などの吸入器技術の進歩が含まれます。生物学的療法とデジタルヘルス技術の出現は、市場を個別化医療ソリューションへと押し上げ、大きな潜在機会を示しています。しかし課題も残っており、高コスト、誤用の可能性、規制上のハードルといった制約が市場拡大に影響を与えています。使い捨て吸入器に関する環境への懸念も、持続可能性の問題を引き起こしています。技術革新と研究の重点分野には、より環境に優しいデバイスの開発、機械学習アルゴリズムによる吸入技術の改善、データ分析のためのより高度なIoT機能の統合などが含まれます。同市場では、デジタルソリューションと持続可能な慣行への傾斜が強まっており、技術的に先進的で環境に優しい製品に対する需要が増加傾向にあることを示しています。ヘルスケアプロバイダーやハイテク企業とのコラボレーションは、革新的なソリューションを開発するための貴重なパートナーシップを提供する可能性があります。このように、業界は規制状況を乗り切り、研究開発に投資して、機器の誤用や低価格化といった課題を克服しなければならないです。消費者の需要や規制の設定に関するこうした競合考察を活用することで、企業は新たな機会を活用し、競争優位性と市場成長機会を確保することができます。

市場力学：急速に進化する呼吸器吸入器市場の主要市場インサイトを公開

呼吸器吸入器市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の大気汚染率の上昇と呼吸器疾患の発生
  • 肺疾患に対する消費者の意識の高まり
  • 喘息治療の改善に対する政府の関心の高まり
• 市場抑制要因
  • 政府による厳しい吸入器承認規制
• 市場機会
  • 革新的なスマート吸入器のイントロダクション
  • 効果的な吸入薬処方の開発
• 市場の課題
  • 吸入器の誤った使用法と操作上の問題

ポーターの5つの力：呼吸器吸入器市場をナビゲートする戦略的ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：呼吸器吸入器市場における外部からの影響の把握

外部マクロ環境要因は、呼吸器吸入器市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析呼吸器吸入器市場における競合情勢の把握

呼吸器吸入器市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス呼吸器吸入器市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、呼吸器吸入器市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨呼吸器吸入器市場における成功への道筋を描く

呼吸器吸入器市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界の大気汚染率の上昇と呼吸器疾患の発生
    • 肺疾患に対する消費者の意識向上
    • 喘息治療の改善に政府が重点を置く
  • 抑制要因
    • 政府による吸入器の承認に対する厳しい規制
  • 機会
    • 革新的なスマート吸入器のイントロダクション
    • 効果的な吸入薬製剤の開発
  • 課題
    • 吸入器の誤った使用法と操作上の問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 呼吸器吸入器市場：製品タイプ別

• ドライパウダー吸入器
• 定量吸入器
• ネブライザー
• ソフトミスト吸入器

第7章 呼吸器吸入器市場：年齢層別

• 大人
• 小児科

第8章 呼吸器吸入器市場モード別

• デジタル操作デバイス
• 手動操作装置

第9章 呼吸器吸入器市場：疾患適応症別

• 喘息
• 慢性閉塞性肺疾患
• 肺動脈高血圧

第10章 呼吸器吸入器市場：最終用途別

• クリニックと病院
• 薬局
• 呼吸ケアセンター

第11章 南北アメリカの呼吸器吸入器市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の呼吸器吸入器市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの呼吸器吸入器市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AstraZeneca PLC
• Beximco Pharmaceuticals Ltd.
• C.H. Boehringer Sohn Ko. KG
• Cadila Healthcare Ltd.
• Chiesi Farmaceutici S.p.A.
• Cipla Limited
• GlaxoSmithKline PLC
• Heltman Medikal A.S.
• Koninklijke Philips N.V.
• Lupin Limited
• Merck & Co., Inc.
• Microlife Corporation
• Novartis AG
• Opko Health, Inc.
• Rossmax International Ltd.
• Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

• FIGURE 1. RESPIRATORY INHALERS MARKET RESEARCH PROCESS
• FIGURE 2. RESPIRATORY INHALERS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. RESPIRATORY INHALERS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. RESPIRATORY INHALERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. RESPIRATORY INHALERS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. RESPIRATORY INHALERS MARKET DYNAMICS
• TABLE 7. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY SOFT MIST INHALERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DIGITALLY OPERATED DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MANUALLY OPERATED DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PULMONARY ARTERIAL HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CLINICS & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY RESPIRATORY CARE CENTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 42. CANADA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. CANADA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 44. CANADA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 46. CANADA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 69. CHINA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. CHINA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 71. CHINA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 72. CHINA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 73. CHINA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 74. INDIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 75. INDIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 76. INDIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 77. INDIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 78. INDIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 160. ITALY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 161. ITALY RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 162. ITALY RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 163. ITALY RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 164. ITALY RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 180. POLAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 181. POLAND RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 182. POLAND RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 183. POLAND RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 184. POLAND RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 185. QATAR RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 186. QATAR RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 187. QATAR RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 188. QATAR RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 189. QATAR RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 235. RESPIRATORY INHALERS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 236. RESPIRATORY INHALERS MARKET, FPNV POSITIONING MATRIX, 2023

The Respiratory Inhalers Market was valued at USD 2.96 billion in 2023, expected to reach USD 3.24 billion in 2024, and is projected to grow at a CAGR of 9.74%, to USD 5.68 billion by 2030.

The respiratory inhalers market encompasses a range of devices used for the delivery of medication directly into the lungs, primarily benefiting individuals with chronic respiratory conditions like asthma and COPD. The necessity for these inhalers arises from the increasing prevalence of respiratory disorders driven by air pollution, smoking, and a rising geriatric population. Their application is critical in delivering rapid relief or long-term control medication, thereby improving patient compliance and quality of life. The end-use scope spans across home care settings, hospitals, and clinics, emphasizing the need for portable and easy-to-use devices. Key factors influencing the market growth include advancements in inhaler technology, such as smart inhalers that provide dosage tracking and patient reminders, which enhance medication adherence. The emergence of biologic therapies and digital health technologies represents significant potential opportunities, pushing the market toward personalized medicine solutions. However, challenges persist, with limitations like high costs, potential for incorrect usage, and regulatory hurdles impacting market expansion. Environmental concerns regarding disposable inhalers also pose sustainability issues. For innovation and research, focus areas include developing more eco-friendly devices, improving inhalation techniques through machine learning algorithms, and integrating more advanced IoT features for data analytics. The market shows a growing inclination towards digital solutions and sustainable practices, indicating an upward trend in demand for technologically advanced and environmentally friendly products. Collaborations with healthcare providers and tech companies could provide valuable partnerships to develop innovative solutions. Thus, the industry must navigate regulatory landscapes and invest in R&D to overcome challenges like device misuse and affordability. By leveraging these insights into consumer demands and regulatory setups, companies can capitalize on emerging opportunities, ensuring competitive advantage and market growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Respiratory Inhalers Market

The Respiratory Inhalers Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rise in air pollution rate worldwide and occurrence of respiratory disorders
  • Increasing consumer awareness of pulmonary disorders
  • Growing government focus on improving asthma care
• Market Restraints
  • Stringent regulations for inhaler approvals by the government
• Market Opportunities
  • Introduction of innovative smart inhalers
  • Development of effective inhaler medication formulations
• Market Challenges
  • Incorrect usage and operational issues in inhalers

Porter's Five Forces: A Strategic Tool for Navigating the Respiratory Inhalers Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Respiratory Inhalers Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Respiratory Inhalers Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Respiratory Inhalers Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Respiratory Inhalers Market

A detailed market share analysis in the Respiratory Inhalers Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Respiratory Inhalers Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Respiratory Inhalers Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Respiratory Inhalers Market

A strategic analysis of the Respiratory Inhalers Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Respiratory Inhalers Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, Beximco Pharmaceuticals Ltd., C.H. Boehringer Sohn Ko. KG, Cadila Healthcare Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, GlaxoSmithKline PLC, Heltman Medikal A.S., Koninklijke Philips N.V., Lupin Limited, Merck & Co., Inc., Microlife Corporation, Novartis AG, Opko Health, Inc., Rossmax International Ltd., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Respiratory Inhalers Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer, and Soft Mist Inhalers.
• Based on Age Group, market is studied across Adults and Pediatric.
• Based on Mode, market is studied across Digitally Operated Devices and Manually Operated Devices.
• Based on Disease Indication, market is studied across Asthma, Chronic Obstructive Pulmonary Disease, and Pulmonary Arterial Hypertension.
• Based on End-Use, market is studied across Clinics & Hospitals, Pharmacies, and Respiratory Care Center.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in air pollution rate worldwide and occurrence of respiratory disorders
    • 5.1.1.2. Increasing consumer awareness of pulmonary disorders
    • 5.1.1.3. Growing government focus on improving asthma care
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent regulations for inhaler approvals by the government
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of innovative smart inhalers
    • 5.1.3.2. Development of effective inhaler medication formulations
  • 5.1.4. Challenges
    • 5.1.4.1. Incorrect usage and operational issues in inhalers
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Respiratory Inhalers Market, by Product Type

• 6.1. Introduction
• 6.2. Dry Powder Inhaler
• 6.3. Metered Dose Inhaler
• 6.4. Nebulizer
• 6.5. Soft Mist Inhalers

7. Respiratory Inhalers Market, by Age Group

• 7.1. Introduction
• 7.2. Adults
• 7.3. Pediatric

8. Respiratory Inhalers Market, by Mode

• 8.1. Introduction
• 8.2. Digitally Operated Devices
• 8.3. Manually Operated Devices

9. Respiratory Inhalers Market, by Disease Indication

• 9.1. Introduction
• 9.2. Asthma
• 9.3. Chronic Obstructive Pulmonary Disease
• 9.4. Pulmonary Arterial Hypertension

10. Respiratory Inhalers Market, by End-Use

• 10.1. Introduction
• 10.2. Clinics & Hospitals
• 10.3. Pharmacies
• 10.4. Respiratory Care Center

11. Americas Respiratory Inhalers Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Respiratory Inhalers Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Respiratory Inhalers Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AstraZeneca PLC
• 2. Beximco Pharmaceuticals Ltd.
• 3. C.H. Boehringer Sohn Ko. KG
• 4. Cadila Healthcare Ltd.
• 5. Chiesi Farmaceutici S.p.A.
• 6. Cipla Limited
• 7. GlaxoSmithKline PLC
• 8. Heltman Medikal A.S.
• 9. Koninklijke Philips N.V.
• 10. Lupin Limited
• 11. Merck & Co., Inc.
• 12. Microlife Corporation
• 13. Novartis AG
• 14. Opko Health, Inc.
• 15. Rossmax International Ltd.
• 16. Teva Pharmaceutical Industries Ltd.